Osiris Therapeutics (OSIR) Tops Q3 EPS by 3c
Tweet
Share
E-mailGet Alerts OSIR Hot Sheet
Price: $18.99 --0%
Financial Fact:
Income before income taxes: -790K
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Income before income taxes: -790K
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Osiris Therapeutics (NASDAQ: OSIR) reported Q3 EPS of $0.02, $0.03 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $17.2 million versus the consensus estimate of $14.8 million.
For earnings history and earnings-related data on Osiris Therapeutics (OSIR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- L3Harris CEO steps down amid conduct review, shares drop
- Motorsport Games Inc. (MSGM) Tops Q2 EPS by 33c
- Onemeta reports 500% usage rise and $2.4M cash flow in H1 2026
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
